Phase I trial of KP 201 (benzhydrocodone/paracetamol) in Canada.

Trial Profile

Phase I trial of KP 201 (benzhydrocodone/paracetamol) in Canada.

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 12 Nov 2015

At a glance

  • Drugs Benzhydrocodone/paracetamol (Primary)
  • Indications Acute pain
  • Focus Adverse reactions
  • Sponsors KemPharm
  • Most Recent Events

    • 12 Nov 2015 According to KemPharm Inc. media release, the company reported positive data of tamper-resistant properties of KP201/APAP.
    • 25 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top